Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USANA Q4 results

This article was originally published in The Tan Sheet

Executive Summary

USANA Health Sciences announces Jan. 10 it expects net sales for its fourth quarter ended Dec. 30, 2006 to be approximately $101 mil. before it reclassifies its financial report. The Salt Lake City-based firm says it will make an "immaterial reclassification to its consolidated financial statements beginning with the fourth quarter of 2006." USANA says the reclassification will reduce net sales by approximately 1.5%. The firm also says it anticipates net sales for full-year 2006 to be approximately $374 mil. The company also says it commenced operations in Malaysia on Jan. 8...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100127

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel